Table 3.
Features | B | Wald | HR (95% CI) | P value |
---|---|---|---|---|
Univariate Cox regression | ||||
ISS stage III | 0.829 | 7.932 | 2.291 (1.286‐4.080) | 0.005* |
Age ≥60 y | 0.454 | 3.529 | 1.575 (0.981‐2.529) | 0.060 |
Beta‐2‐MG>5.5 mg/dL | 0.829 | 7.923 | 2.291 (1.286‐4.080) | 0.005* |
Creatinine>176.8 µmol/L | 0.192 | 0.481 | 1.211 (0.705‐2.081) | 0.488 |
CD117(+) | −0.523 | 3.992 | 0.593 (0.355‐0.990) | 0.046* |
CD81(+) | 0.779 | 10.335 | 2.179 (1.355‐3.505) | 0.001* |
Multivariate Cox regression | ||||
ISS stage III | 0.723 | 5.952 | 2.061 (1.153‐3.685) | 0.015* |
Beta‐2‐MG>5.5 mg/dL | 0.326 | 0.928 | 1.358 (0.714‐2.688) | 0.335 |
CD117(+) | −0.318 | 1.374 | 0.727 (0.427‐1.239) | 0.241 |
CD81(+) | 0.582 | 5.299 | 1.790 (1.090‐2.940) | 0.021* |
P < 0.05.